Medical school professors said both the government and the medical community should make concessions to resolve the current situation. Still, the government has stuck to its stance of increasing the medical school enrollment quota by 2,000 per year.Bang Jae-seung, head of the National Medical School
D&D Pharmatech, a Korean biotech company, said it expanded its collaboration with the U.S.-based Metsera for new treatments. This expansion includes amendments to a previously established agreement for an oral obesity treatment and the initiation of a new global technology transfer agreement for an
AITRICS, a healthcare artificial intelligence (AI) company, has unveiled AITRICS-VC (VitalCare), an AI solution for predicting patient deterioration, at major medical device exhibitions in Korea and the United States.AITRICS said Monday that it participated in the HIMSS 2024 Global Health Exhibition
Boston Scientific said Monday that it would expand technical support for the Lumenis Pulse 120H Holmium Laser System based on the MOSES technology and further strengthen its leadership in stone treatment in Korea.According to Boston Scientific, the company has recently enhanced the expertise of its
Lunit said it signed contracts to supply its AI solutions to France's largest teleradiology network, TeleDiag, and the Central Center of the Portuguese Cancer League (Liga Portuguesa Contra o Cancro, LPCC), a prominent nonprofit organization in Portugal.Lunit has recently secured a contract with Tel
CHA Biotech said Monday that it has signed a contract development and manufacturing organization (CDMO) agreement with Cell in Cells, a regenerative medicine cell therapies developer, to provide organoid treatment for cartilage diseases.Under the agreement, CHA Biotech will establish a cell bank of
The Korea Research Institute of Bioscience & Biotechnology (KRIBB) said Monday that a joint research team has developed a platform that can quickly detect multiple respiratory viruses in the field.The state-run institute said it will likely be used as a basis for developing diagnostic devices in the
Following last year's initiation, the Ministry of Food and Drug Safety (MFDS) is set to implement the Big Tech Regulatory Innovation Program this year. This year's program will see the participation of four new companies: Samsung Electronics, Samsung Fire and Marine Insurance, Hyundai Motor, and SKT
Celltrion officially launched Zymfentra, also known as Remsima SC in Europe, in the U.S., last Friday.Zymfentra is the world's only subcutaneous (SC) form of infliximab, having received FDA approval in October of the previous year. Under the approval, the drug can treat moderate to severe active ulc
Lee Jin-a was appointed as the first Korean President and CEO of Bayer Korea in October of last year, a noteworthy event in the company's history spanning nearly 70 years. This appointment highlights the changing dynamics and strategic priorities of the Korean healthcare industry within the multinat
In a show of international solidarity, the Medical Women's International Association (MWIA) has issued a strong statement in support of the Korean Medical Women's Association (KMWA) following a gender-biased statement made by a high-level Korean government official in Seoul, Korea, this past Februar
The Korea Health Industry Development Institute (KHIDI) has inked a memorandum of understanding (MOU) with the Medical Research Council (MRC), part of the U.K.’s Research and Innovation (UKRI).UKRI, overseeing an impressive budget of approximately 14 trillion won ($11 billion) as of last year, funct
NeoImmuneTech said Friday that its board of directors has decided to establish a Polish subsidiary to prepare for full-scale clinical trials in the European market.NeoImmuneTech expects that the Polish subsidiary's possible designation as a European small and medium enterprise (SME) will enable it t
Interns and residents who resigned en masse to oppose the increase of medical school enrollment quota will likely face de facto license revocation if they fail to return to their hospitals and complete their training.The government, which does not allow resigned medical residents to work at other ho
Bayer Korea's Kerendia (ingredient: finerenone), a novel non-steroidal mineralocorticoid receptor antagonist (MRA), is garnering significant attention from local physicians as a potential game-changer in the treatment of chronic kidney disease (CKD) associated with type 2 diabetes.The drug, which ta
The 39th Korea International Medical and Hospital Equipment Show (KIMES) 2024, which opened on Thursday, attracted visitors' attention with more than 13,000 products related to the medical industry, especially AI-based smart healthcare and robotics.KIMES 2024, which will continue through Sunday, mor
To the Chairperson of the Korean Federation of Severe Disease Patients,Dear Chairperson Kim Sung-joo,I would like to express my respect for your dedication to protecting the rights and interests of severely ill patients on behalf of the seven organizations representing patients with the most challen
Legal experts debated the effective timing of trainee physicians' resignation letters at a meeting convened by Rep. Shin Hyun-young of the Democratic Party of Korea, titled "How to interpret the legal issues related to the medical crisis," held at the National Assembly on Thursday.Recently, the gove
After the government announced it would stop providing free Covid-19 drugs and start charging for them in the first half of this year, concerns are growing about a treatment gap due to delays in discussing the reimbursement of related medications.According to the Korea Disease Control and Prevention
The Korean government has requested drug distributors to prioritize the distribution of immunoglobulin products, utilized in treating immunodeficiency in pediatric and critically ill patients, to children's hospitals.Nam Hoo-hee, head of the Pharmaceutical Policy Division at the Ministry of Health a